Xenon Pharmaceuticals Inc. Revenue 2012–2025
Xenon Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Xenon Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Xenon Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 7.5 M, a 5581.82% increase year-over-year.
- Xenon Pharmaceuticals Inc. annual revenue for 2025 was 7.5 M.
- Xenon Pharmaceuticals Inc. annual revenue for 2024 was 0.
- Xenon Pharmaceuticals Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
- Xenon Pharmaceuticals Inc. annual revenue for 2022 was 9.4 M.
Xenon Pharmaceuticals Inc. (XENE) — Frequently Asked Questions
Xenon Pharmaceuticals Inc. (XENE) is a publicly traded US company. It has a market capitalization of $4.07B. In fiscal 2025 it reported revenue of $8M and net income of -$346M. Explore XENE's stock price, financial statements, earnings history, margins and key ratios below.
What is Xenon Pharmaceuticals Inc.'s market cap?
Xenon Pharmaceuticals Inc. (XENE) has a market capitalization of $4.07B.
What is the XENE stock price?
XENE trades at $51.34 (-2.75% on the day).
How much revenue does Xenon Pharmaceuticals Inc. make?
Xenon Pharmaceuticals Inc. reported revenue of $8M in fiscal 2025.
Is XENE profitable?
In fiscal 2025, Xenon Pharmaceuticals Inc. reported net income of -$346M.